Key points are not available for this paper at this time.
Efficacy of dual FLT3/LSD1 inhibition in primary AML samples.
Yashar et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: